569 related articles for article (PubMed ID: 26185095)
1. A novel "humanized mouse" model for autoimmune hepatitis and the association of gut microbiota with liver inflammation.
Yuksel M; Wang Y; Tai N; Peng J; Guo J; Beland K; Lapierre P; David C; Alvarez F; Colle I; Yan H; Mieli-Vergani G; Vergani D; Ma Y; Wen L
Hepatology; 2015 Nov; 62(5):1536-50. PubMed ID: 26185095
[TBL] [Abstract][Full Text] [Related]
2. The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model.
Yuksel M; Xiao X; Tai N; Vijay M; Gülden E; Beland K; Lapierre P; Alvarez F; Hu Z; Colle I; Ma Y; Wen L
Clin Exp Immunol; 2016 Nov; 186(2):164-176. PubMed ID: 27414259
[TBL] [Abstract][Full Text] [Related]
3. A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens.
Lapierre P; Djilali-Saiah I; Vitozzi S; Alvarez F
Hepatology; 2004 Apr; 39(4):1066-74. PubMed ID: 15057911
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview.
Dalekos GN; Zachou K; Liaskos C; Gatselis N
Eur J Intern Med; 2002 Aug; 13(5):293-303. PubMed ID: 12144908
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.
Zachou K; Rigopoulou E; Dalekos GN
J Autoimmune Dis; 2004 Oct; 1(1):2. PubMed ID: 15679907
[TBL] [Abstract][Full Text] [Related]
6. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
Manns MP; Obermayer-Straub P
Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
[TBL] [Abstract][Full Text] [Related]
7. Autoimmmune hepatitis.
Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D
Cell Mol Immunol; 2022 Feb; 19(2):158-176. PubMed ID: 34580437
[TBL] [Abstract][Full Text] [Related]
8. Genetic association of autoimmune hepatitis and human leucocyte antigen in German patients.
Teufel A; Wörns M; Weinmann A; Centner C; Piendl A; Lohse AW; Galle PR; Kanzler S
World J Gastroenterol; 2006 Sep; 12(34):5513-6. PubMed ID: 17006990
[TBL] [Abstract][Full Text] [Related]
9. Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model.
Hintermann E; Holdener M; Bayer M; Loges S; Pfeilschifter JM; Granier C; Manns MP; Christen U
J Autoimmun; 2011 Nov; 37(3):242-53. PubMed ID: 21795021
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model.
Müller P; Messmer M; Bayer M; Pfeilschifter JM; Hintermann E; Christen U
J Autoimmun; 2016 May; 69():51-8. PubMed ID: 26924542
[TBL] [Abstract][Full Text] [Related]
11. The influence of genetic predisposition and autoimmune hepatitis inducing antigens in disease development.
Hardtke-Wolenski M; Dywicki J; Fischer K; Hapke M; Sievers M; Schlue J; Anderson MS; Taubert R; Noyan F; Manns MP; Jaeckel E
J Autoimmun; 2017 Mar; 78():39-45. PubMed ID: 27974250
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune hepatitis.
Obermayer-Straub P; Strassburg CP; Manns MP
J Hepatol; 2000; 32(1 Suppl):181-97. PubMed ID: 10728804
[TBL] [Abstract][Full Text] [Related]
13. Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis.
Longhi MS; Hussain MJ; Kwok WW; Mieli-Vergani G; Ma Y; Vergani D
Hepatology; 2011 Feb; 53(2):536-47. PubMed ID: 21274874
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the antigenicity of the formiminotransferase-cyclodeaminase in type 2 autoimmune hepatitis.
Renous R; Lapierre P; Djilali-Saiah I; Vitozzi S; Alvarez F
Exp Cell Res; 2004 Jan; 292(2):332-41. PubMed ID: 14697341
[TBL] [Abstract][Full Text] [Related]
15. Intestinal microbiome and permeability in patients with autoimmune hepatitis.
Cai W; Ran Y; Li Y; Wang B; Zhou L
Best Pract Res Clin Gastroenterol; 2017 Dec; 31(6):669-673. PubMed ID: 29566910
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T Cells in Autoimmune Hepatitis: Unveiling Their Roles in Mouse Models and Patients.
Wang H; Feng X; Yan W; Tian D
Front Immunol; 2020; 11():575572. PubMed ID: 33117375
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune hepatitis: a classic autoimmune liver disease.
Moy L; Levine J
Curr Probl Pediatr Adolesc Health Care; 2014 Dec; 44(11):341-6. PubMed ID: 25466500
[TBL] [Abstract][Full Text] [Related]
18. Type 2 autoimmune hepatitis: Genetic susceptibility.
Lapierre P; Alvarez F
Front Immunol; 2022; 13():1025343. PubMed ID: 36248826
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study.
Gregorio GV; Portmann B; Karani J; Harrison P; Donaldson PT; Vergani D; Mieli-Vergani G
Hepatology; 2001 Mar; 33(3):544-53. PubMed ID: 11230733
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2.
Longhi MS; Hussain MJ; Bogdanos DP; Quaglia A; Mieli-Vergani G; Ma Y; Vergani D
Hepatology; 2007 Aug; 46(2):472-84. PubMed ID: 17559153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
